Nachweisverfahren in der SARS-CoV-2-Diagnostik – Antigen-, Antikörper-, und Nukleinsäure-basierte Tests

Das Beobachten und die Kontrolle des Verlaufs der SARS-CoV-2-Pandemie erfordert die Identifizierung akut erkrankter Personen, infektiöser Individuen, immuner Personen, von Personen mit zurückliegender Infektion und von Trägern einer Virusvariante mit erhöhtem pathogenem Potenzial. Jede Analysemethode adressiert diese Anforderungen unterschiedlich gut, sodass sie je nach Fragestellung differenziert eingesetzt werden müssen.

• Literatur

• 1 Quasem A, Shaw AM, Elkamel E. et al. Coronavirus disease 2019 (COVID-19) diagnostic tools: A focus on detection technologies and limitations. Curr Issues Mol Biol 2021; 43: 728-748
• 2 van Kampen JJA, van de Vijver DAMC, Fraaij PLA. et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease 2019 (COVID-19). Nat Commun 2021; 12: 267-273
• 3 Nomura T, Kitagawa H, Omori K. et al. Duration of infectious virus shedding in patients with severe coronavirus disease 2019 who required mechanical ventilation. J Infect Chemother 2021;
• 4 Lee HK, Lee BH, Seok SH. et al. Production of specific antibodies against SARS.coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43. J Vet Sci 2010; 11: 165-167
• 5 Krüttgen A, Cornelissen CG, Dreher M. et al. Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche, and IDvet. J Virol Methods 2020; 287: 113978
• 6 Souza Machado BA, Saraiva Hodel KV, Barbosa Junior VG. et al. The main molecular and serological methods for diagnosing COVID-19: An overview based on the literature. Viruses 2021; 13: 40
• 7 Trombetta BA, Kandigian SE, Kitchen RR. et al. Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus 2. BMC Infect Dis 2021; 21: 580
• 8 Krüttgen A, Lauen M, Klingel H. et al. Two novel SARS-CoV-2 surrogate virus neutralization assay are suitable for assessing successful immunization with mRNA-1273. J Virol Methods
• 9 Krüttgen A, Klingel H, Haase G. et al. Evaluation of the QuantiFERON SARS-CoV-2 Inferon-γ release assay in mRNA-1273 vaccinated health care workers. J Virol. Methods
• 10 Brümmer LE, Katzenschlager S, Gaeddert M. et al. Accuracy of novel abtigen rapid diagnostics for SARS-CoV-2: A living systematic review and metaanalysis. PLoS Med 2021;
• 11 Wu S, Shi X, Chen Q. et al. Comparative evaluation of six nucleic acid amplification kits for SARS-CoV-2 detection. Ann Clin Microbiol Antimicrob 2021; 20: 38
• 12 Musumeci A, Vinci M, L’Episcopo F. et al. Implementation of simple pooling procedure using a rapid SARS-CoV-2 diagnostic real time PCR test performed prior to hospital admission of people with intellectual disabilities. Int J Environ Res Public Health 2021; 18: 9317
• 13 Jones L, Bakre A, Naikare H. et al. Isothermal amplification and fluorescent detection of SARS-CoV-2 and SARS-CoV-2 variant virus in nasopharyngeal swabs. PLoS One 2021; 16: e0257563
• 14 Banada P, Green R, Banik S. et al. A simple reverse transcriptase PCR melting temperature assay to rapidly screen for widely circulating SARS-CoV-2 variants. J Clin Microbiol 2021; 59: e0084521